GSK plc (LSE/NYSE: GSK) today announced new data from the AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial evaluating the efficacy and safety of a single dose of AREXVY (Respiratory ...
Get multi-device protection for you and your family. Protect your phones and computers against new and existing threats with continuous antivirus and phishing scans 7. Get alerted if malicious apps ...